CCM
PGNX
Cadence Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-260,046
| Closed | -$1.55M | – | 716 |
|
|
2017
Q4 | $1.55M | Buy |
260,046
+18,770
| +8% | +$112K | 0.1% | 276 |
|
|
2017
Q3 | $1.78M | Buy |
241,276
+48,863
| +25% | +$360K | 0.11% | 214 |
|
|
2017
Q2 | $1.31M | Buy |
192,413
+79,500
| +70% | +$540K | 0.09% | 288 |
|
|
2017
Q1 | $1.07M | Buy |
112,913
+46,365
| +70% | +$438K | 0.07% | 335 |
|
|
2016
Q4 | $575K | Sell |
66,548
-121,751
| -65% | -$1.05M | 0.04% | 483 |
|
|
2016
Q3 | $1.19M | Sell |
188,299
-4,376
| -2% | -$27.7K | 0.09% | 267 |
|
|
2016
Q2 | $813K | Buy |
192,675
+37,048
| +24% | +$156K | 0.06% | 345 |
|
|
2016
Q1 | $679K | Buy |
155,627
+27,610
| +22% | +$120K | 0.05% | 407 |
|
|
2015
Q4 | $785K | Sell |
128,017
-21,136
| -14% | -$130K | 0.05% | 369 |
|
|
2015
Q3 | $853K | Sell |
149,153
-14,507
| -9% | -$83K | 0.06% | 333 |
|
|
2015
Q2 | $1.22M | Buy |
+163,660
| New | +$1.22M | 0.07% | 365 |
|